Growing evidence on Oxford shot should guide other countries, vaccine chief says By Reuters
LONDON (Reuters) - Real-world data on the effectiveness of Oxford and AstraZeneca (NASDAQ:AZN)'s COVID-19 vaccine in older people from its rollout in Britain should help inform decision making in other countries, Oxford Vaccine Group Director Andrew Pollard said on Tuesday. Asked if other countries should look at real world data from Public Health...
Continue reading